
Article
Why healthcare innovation stalls: what the published evidence says
Four published measures of how often healthcare innovations fall short, what each one actually counts, and why none of them should be averaged.
HealthTech Navigators (HTN) is a healthcare advisory group that turns promising innovations into practical plans and measurable progress for healthcare technology, medical devices, medtech, and pharma.
Every engagement is evidence-based, and every assessment stays confidential.
Typical initial assessment
Average years of senior experience
Team and Advisory Board members
Clinicians see a product that solves a real problem. Healthcare decision-makers need a reason to buy it. Getting it to market takes funding, regulatory approval, reliable manufacturing and a clear global go-to-market plan.
We help turn good healthcare ideas into commercial success.

We only work in medical devices, medtech and pharma. Within them, HTN covers the whole path, from first assessment to investors, development, regulatory, manufacturing and commercialization, so you aren’t handed from one consultant to the next.
Turn a promising concept into a milestone-driven development and funding strategy.
Evaluate an opportunity against your thesis and stage requirements, and against how ready the company actually is.
HTN works out what is going wrong and brings in the specialists to fix it.
HTN is AI-infused but expert-led: AI gathers the data, experienced people decide what matters for the next milestone.
The example on the right is a hypothetical medical-device company preparing its seed round. Three gaps decide whether the raise happens.
Explore our processIllustrative example
Plan the clinical evidence the next investors will ask to see.
Services shaped around whether you’re building a healthcare company or investing in one. HTN can stay involved after the first engagement, through the next challenge and the next milestone.
See our services
Article
Four published measures of how often healthcare innovations fall short, what each one actually counts, and why none of them should be averaged.

Case study
HTN found limited clinical evidence and incomplete reimbursement pathway data.

Article
Why HTN is backing a history of minimally invasive surgery.
Healthcare operators, investors and commercial leaders who have built, sold and advised in the US and Europe.
Meet the team
Walker Lambiotte
Chief Executive Officer

Steve Marsh
Chief Operating Officer

James Gibbons
Chief Business Development Officer

Ivan George
Founder & Chief Technology Officer